Cargando…

TAS‐115 inhibits PDGFRα/AXL/FLT‐3 signaling and suppresses lung metastasis of osteosarcoma

Osteosarcoma is the most common malignant bone tumor in adolescence and childhood. Metastatic osteosarcoma has a poor prognosis with an overall 5‐year survival rate of approximately 20%. TAS‐115 is a novel multiple receptor tyrosine kinase inhibitor that is currently undergoing clinical trials. Usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yasuda, Naohiro, Takenaka, Satoshi, Nakai, Sho, Nakai, Takaaki, Yamada, Shutaro, Imura, Yoshinori, Outani, Hidetatsu, Hamada, Kenichiro, Yoshikawa, Hideki, Naka, Norifumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193166/ https://www.ncbi.nlm.nih.gov/pubmed/32128992 http://dx.doi.org/10.1002/2211-5463.12827

Ejemplares similares

Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma
por: Yamada, Shutaro, et al.
Publicado: (2017)

Functional and therapeutic relevance of hepatocyte growth factor/c‐MET signaling in synovial sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2016)

Clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration
por: Outani, Hidetatsu, et al.
Publicado: (2020)

Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
por: Nakai, Takaaki, et al.
Publicado: (2017)

Author Correction: Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs
por: Nakai, Sho, et al.
Publicado: (2020)

Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs
por: Nakai, Sho, et al.
Publicado: (2019)

Clinical Outcomes and Prognostic Factors for Patients with Malignant Peripheral Nerve Sheath Tumour
por: Imura, Yoshinori, et al.
Publicado: (2021)

Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma
por: Imura, Yoshinori, et al.
Publicado: (2022)

Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma
por: Imura, Yoshinori, et al.
Publicado: (2014)

18F-Fluorodeoxyglucose Positron Emission Tomography Is Useful in the Evaluation of Prognosis in Retroperitoneal Sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2021)

Targeting the Clear Cell Sarcoma Oncogenic Driver Fusion Gene EWSR1::ATF1 by HDAC Inhibition
por: Mae, Hirokazu, et al.
Publicado: (2023)

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS
por: Outani, Hidetatsu, et al.
Publicado: (2014)

Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study
por: Kawai, Akira, et al.
Publicado: (2021)

A giant periosteal chondroma of the distal femur successfully reconstructed with synthetic bone grafts and a bioresorbable plate: a case report
por: Imura, Yoshinori, et al.
Publicado: (2014)

Clinical Outcomes of Osteoarticular Extracorporeal Irradiated Autograft for Malignant Bone Tumor
por: Takenaka, Satoshi, et al.
Publicado: (2020)

Impact of Surgical Resection and Reasons for Poor Prognosis of Pelvic Osteosarcoma Based on the Bone Tumor Registry in Japan
por: Takenaka, Satoshi, et al.
Publicado: (2021)

Clinical outcomes for patients with synovial sarcoma of the hand
por: Outani, Hidetatsu, et al.
Publicado: (2014)

Intraoperative extracorporeal autogenous irradiated tendon grafts for functional limb salvage surgery of soft tissue sarcomas of the wrist and hand
por: Omori, Shinsuke, et al.
Publicado: (2015)

A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo
por: Imura, Yoshinori, et al.
Publicado: (2013)

Malignant peripheral nerve-sheath tumors in an adolescent patient with mosaic localized NF1: A case report
por: Hagizawa, Hiroki, et al.
Publicado: (2020)

Intercalary endoprosthesis for salvage of failed intraoperative extracorporeal autogeneous irradiated bone grafting (IORBG) reconstruction
por: Hamada, Kenichiro, et al.
Publicado: (2014)

Phase I study of TAS-115, a novel oral multi-kinase inhibitor, in patients with advanced solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2019)

Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer
por: Imura, Yoshinori, et al.
Publicado: (2020)

Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis
por: Tamiya, Hironari, et al.
Publicado: (2018)

Reply to the letter to the editor concerning the article “clinical outcomes of chondroblastoma treated using synthetic bone substitute: risk factors for developing radiographic joint degeneration”
por: Outani, Hidetatsu, et al.
Publicado: (2021)

Rectotumoral fistula formation occurring more than 5 years after carbon ion radiotherapy for sacral chordoma: A case report
por: Ukon, Yuichiro, et al.
Publicado: (2019)

A case of Stewart-Treves syndrome occurring in the abdominal wall successfully treated with eribulin: A case report
por: Imura, Yoshinori, et al.
Publicado: (2020)

Novel AXL-targeted agents overcome FLT3 inhibitor resistance in FLT3-ITD(+) acute myeloid leukemia cells
por: Liu, Yi, et al.
Publicado: (2021)

WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine
por: Alzaaqi, Shouq, et al.
Publicado: (2022)

Direct Induction of Chondrogenic Cells from Human Dermal Fibroblast Culture by Defined Factors
por: Outani, Hidetatsu, et al.
Publicado: (2013)

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
por: Mori, Masamichi, et al.
Publicado: (2017)

Giant cell tumor of bone – Analysis of 213 cases involving extra‐craniofacial bones
por: Konishi, Eiichi, et al.
Publicado: (2021)

Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer
por: Yeh, Chen-Yun, et al.
Publicado: (2011)

Design of phase 2 study of TAS-115, a novel oral multi-kinase inhibitor, in patients with idiopathic pulmonary fibrosis
por: Nishioka, Yasuhiko, et al.
Publicado: (2021)

GZD824 as a FLT3, FGFR1 and PDGFRα Inhibitor Against Leukemia In Vitro and In Vivo
por: Wang, Yuting, et al.
Publicado: (2020)

The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors
por: Qiu, Yang, et al.
Publicado: (2023)

A case report of pancreatic metastasis from synovial sarcoma successfully treated by metastasectomy with adjuvant chemotherapy
por: Makino, Yuki, et al.
Publicado: (2016)

Deflection of vascular endothelial growth factor action by SS18–SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma
por: Wakamatsu, Toru, et al.
Publicado: (2014)

Shieldings: TAS
Publicado: (2004)

Shieldings: TAS
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_petcnf47r3gs34fc8j2mpnkj0g